2026-04-25T03:08:53Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:28928 2025-12-19T04:43:49Z

Bevacizumab in combination with irinotecan and capecitabine as first line treatment for MCRC efficacy and safety. /unibl/sci/idNaucniRad:7053 Conference Paper text 2014-06 С. Јунгић, G. Kecman Malčić, И. Ракита, D. Jovanović, R. Gajanin, З. Марић, T. Biljana, З. Гојковић, Bevacizumab in combination with irinotecan and capecitabine as first line treatment for MCRC efficacy and safety., Annals of Oncology 2014; 25 (Supplement 2):, pp. 68 - 68, Jun, 2014 http://annonc.oxfordjournals.org/search?submit=yes&tocsectionid=symposium%20article&volume=25&issue=suppl%202 68 68 ESMO 16th World Congress on Gastrointestinal Cancer Annals of Oncology 2014; 25 (Supplement 2): https://www.unibl.org/sr-lat/fis/zaposlen/3512-sasa-jungic /unibl/author/Gordana Kecman Malčić /unibl/author/Ivanka Rakita /unibl/author/Dušan Jovanović https://www.unibl.org/sr-lat/fis/zaposlen/3346-radoslav-gajanin /unibl/author/Zdravko Marić /unibl/author/Tubić Biljana https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic https://med.unibl.org ESMO 16th World Congress on Gastrointestinal Cancer Annals of Oncology 2014; 25 (Supplement 2): 68 68 https://www.unibl.org/sr-lat/fis/zaposlen/3512-sasa-jungic /unibl/author/Gordana Kecman Malčić /unibl/author/Ivanka Rakita /unibl/author/Dušan Jovanović https://www.unibl.org/sr-lat/fis/zaposlen/3346-radoslav-gajanin /unibl/author/Zdravko Marić /unibl/author/Tubić Biljana https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic https://www.pub.unibl.org/s/cir/item/28928